<?xml version="1.0" encoding="UTF-8"?>
<p>Serum samples were collected from 182 dengue patients in the acute-phase of infection originated from five provinces in Southern Thailand; namely Nakhon Si Thammarat, Narathiwat, Pattani, Satun and Songkhla (
 <xref ref-type="fig" rid="pone.0221179.g001">Fig 1</xref> and Supplementary 
 <xref ref-type="supplementary-material" rid="pone.0221179.s001">S1 Table</xref>). Only patients exhibiting febrile illness (temperature &gt;38Â°C), and who were suspected of arbovirus infection, according to the World Health Organization (WHO) guideline for dengue diagnosis were included in the study [
 <xref rid="pone.0221179.ref030" ref-type="bibr">30</xref>]. Serological testing was performed on patient blood samples using a rapid DENV non-structural protein 1 (NS1) antibody test (SD BIOLINE Dengue Duo rapid test; Abbot Laboratories, Bangkok, Thailand). Description of study population is recorded in 
 <xref ref-type="supplementary-material" rid="pone.0221179.s001">S1 Table</xref>.
</p>
